Capital One Financial began coverage on shares of Immutep (NASDAQ:IMMP – Free Report) in a research note released on Friday, Marketbeat reports. The brokerage issued an overweight rating and a $10.00 price target on the biotechnology company’s stock. Immutep Stock Performance NASDAQ IMMP opened at $3.10 on Friday. Immutep has a 1 year low of […]
UBS Group AG decreased its position in First Trust Low Duration Opportunities ETF (NASDAQ:LMBS – Free Report) by 5.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,498,247 shares of the company’s stock after selling 199,684 shares during the quarter. UBS Group AG’s […]
Balentine LLC lifted its position in GSK plc (NYSE:GSK – Free Report) by 13.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,449 shares of the pharmaceutical company’s stock after acquiring an additional 3,032 shares during the quarter. Balentine LLC’s […]
Beutel Goodman & Co Ltd. grew its position in GSK plc (NYSE:GSK – Free Report) by 54.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,050 shares of the pharmaceutical company’s stock after purchasing an additional 4,620 shares during the quarter. Beutel […]
Meridian Wealth Management LLC acquired a new position in shares of Comerica Incorporated (NYSE:CMA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,585 shares of the financial services provider’s stock, valued at approximately $200,000. Several other institutional investors have also recently […]